In addition, the risk for cancer progression/recurrence increased significantly if CCNH–C5orf30 (P = 0.026) or ZMPSTE24–ZMYM4 (P = 0.024) was detected in the serum samples after treatment. The gene discussed is ZMYM4; the disease is cancer.